• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Pediatr (Phila) . The Use of Antigenic SARS-CoV-2 Point-of-Care Test: The Italian Pediatric Real-Life Experience

tetano

Editor, Senior Moderator
Clin Pediatr (Phila)


. 2021 Nov 8;99228211053916.
doi: 10.1177/00099228211053916. Online ahead of print.
The Use of Antigenic SARS-CoV-2 Point-of-Care Test: The Italian Pediatric Real-Life Experience


Federica Ferrari[SUP] 1 [/SUP], Fortunata Civitelli[SUP] 1 [/SUP], Francesca Ardenti Morini[SUP] 1 [/SUP], Federico Angelo Carmelo Buonaiuto[SUP] 1 [/SUP], Gianluca Frega[SUP] 1 [/SUP], Francesca Fabbri[SUP] 1 [/SUP], Mauro Ioppi[SUP] 1 [/SUP], Alberto Maione[SUP] 1 [/SUP], Elena Minniti De Simeonibus[SUP] 1 [/SUP], Francesca Soscia[SUP] 1 [/SUP], Piera Torre[SUP] 1 [/SUP], Francesca Toselli[SUP] 1 [/SUP], Elisabetta Cortis[SUP] 1 [/SUP]



Affiliations

Abstract

In Italy, during the second epidemic wave of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), rapid antigenic (Ag) test at point-of-care (POCT) station were employed to quickly evaluate large numbers of swabs. We collected data of all children who underwent the Ag test in our hospital. All positive patients were recalled to perform reverse transcription polymerase chain reaction. A total of 2133 tests were collected over 1 month. Clinical data of 1941 children (median age = 3.7 years) were analyzed: 1343 (69.2%) patients complained of symptoms, 594 (30.6%) had a history of close contact with SARS-CoV-2-positive individuals. Among symptoms reported, acute rhinitis was the most frequent (67.9%), followed by cough (42.6%) and fever (31.5%). Among all tests, 95.8% resulted negative, 4.2% positive: 37/89 were confirmed. In confirmed cases, fever (56.2% vs 32.2%; P = .041) and gastrointestinal symptoms (18.8% vs 6.25%; P = .041) were significantly more frequent compared with negative children. The use of POCT for Ag test seems appropriate for SARS-CoV-2 screening in the pediatric population. In children, fever and gastrointestinal symptoms may constitute red flags of SARS-CoV-2.

Keywords: COVID-19; children; close contact; nasal swab.
 
Back
Top Bottom